Drug-releasing Contact Lenses

Blog vol 4.40. Drug-releasing Contact Lenses


Back in 2022, Health Canada approved the use of a revolutionary method of drug delivery to the eye. Johnson & Johnson had developed a contact lens called Theravision which allowed a patient to wear a daily lens that released a reliable antihistamine, ketotefin, slowly over the course of the day. Some of our patients are on them and they do work. Two advantages:  no preservatives involved (the usual antihistamine drops have preservatives in them) and the patient gets full-day coverage. Unfortunately, J & J has decided to stop distributing these lenses in Canada. 


The idea of using a contact lens for delivering a drug is groundbreaking.


The results from a phase 2b study on a new contact lens with glaucoma therapy have just been released (available here).


This lens is a silicone hydrogel, unlike the HEMA material of the J & J product, and it is worn extended-wear for three weeks (24/7). During that time, the drug, bimatoprost, a proven anti-glaucoma agent is gradually released. Results are promising: pressures were the same as when using a drop of 0.01% bimatoprost nightly (the standard treatment for glaucoma), but no nasty preservatives, no missed drops, and no improperly administered drops.  The contact lens releases directly on the eye with less potential side effects and even contains a lubricant. 


This is very promising.  It is just the beginning. Imagine being able to infuse a lens with any number of therapies, be it antibacterial, anti-inflammatory, antiviral, antifungal, or for dry eye therapies, growth factors. The company, Mediprint Ophthalmics, will now be conducting phase 3 studies with the hope of bringing this technology to market.   


What a good idea! The tricky part would be to ensure that the drug is released consistently and gradually over the whole period of wear. If this is attainable, these lenses could lead to improved, more consistent treatment results for all patients, a very worthwhile achievement. 



Til next week,


 

The good doctor       

    

P.S.  Just received all our pairs of solar eclipse glasses!  Mark your calendar: APRIL 8, FULL SOLAR ECLIPSE, right here in Burlington! Need eclipse glasses? Come pick up a pair at Burlington Eyecare anytime.                   


By Dr. Mark Germain October 30, 2025
The good doctor discusses some of the latest research into visual prosthetics. Get ready to be amazed!
By Dr. Mark Germain October 24, 2025
Noticing the things that only an optometrist can, the good doctor discusses the vision of needs of star baseball players.
By Dr. Mark Germain October 16, 2025
The good doctor discusses exciting continued research being done into gene therapy for conditions such as Leber's congenital amaurosis.
By Dr. Mark Germain October 9, 2025
Inspired by an article he recently read, the good doctor takes another look at natural UV light and its benefits.
By Dr. Mark Germain October 2, 2025
The good doctor discusses some recent options for managing myopia in children.
By Dr. Mark Germain September 24, 2025
The good doctor offers some insight into the latest research in dry eye management.
More Posts